Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FUJQS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,553
Award facts
- Contract value 100% obligated
- $12,553.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $12,553.15 and an ultimate completion date of August 4, 2025. This award was made without a set-aside designation, and the place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group is fulfilling this order under its existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide.
EXPAREL (liposomal bupivacaine) is a long-acting local anesthetic used for post-operative pain management in surgical settings. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in DLA procurement markets. The company's extensive portfolio of federal contract awards demonstrates consistent success in delivering branded and generic pharmaceuticals, biologics, and medical consumables to Department of Defense healthcare facilities nationwide, positioning it as a reliable vendor for specialized pharmaceutical products supporting military medical operations.
Quick answers
Who was awarded contract SPE2DB25FUJQS?
SPE2DB25FUJQS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FUJQS worth?
The government has obligated $12,553 on SPE2DB25FUJQS.
Is contract SPE2DB25FUJQS an order under another contract?
Yes. SPE2DB25FUJQS is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJQS competed?
The extent of competition for SPE2DB25FUJQS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award